Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Matthew Bobel

Colon & Rectal Surgery Salt Lake City, UT Medical Doctor

NPI 1851788046 CMS profile 5549490

1250 E 3900 S Ste 320, Salt Lake City, UT 84124

Open in the dashboard

General payments

$6,405

39 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Bobel of Salt Lake City, UT is reported in the CMS Open Payments database as having received $6,405 across 39 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,157 17
2024 General $299 7
2023 General $1,936 14
2020 General $13 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Bobel
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Matthew Bobel were reported at $4,157. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Matthew Bobel Colon & Rectal Surgery median Middle half National median
2019 $0 $443 $125–$2,179 $163
2020 $13 $167 $53–$931 $114
2021 $0 $207 $72–$1,272 $132
2022 $0 $341 $111–$1,587 $149
2023 $1,936 $322 $115–$1,420 $160
2024 $299 $328 $112–$1,354 $164
2025 $4,157 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Intuitive Surgical, Inc. $5,670 29 payments
  2. Medtronic, Inc. $644 6 payments
  3. Innovation Technologies Inc $36 1 payment
  4. Integra LifeSciences Corporation $21 1 payment
  5. Ethicon US, LLC $19 1 payment
  6. Distalmotion US $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Education $2,718 2 payments
  2. Travel and Lodging $2,523 18 payments
  3. Food and Beverage $864 18 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $300 1 payment
Products named General payments · program years 2020–2025
  1. Da Vinci Surgical System $2,870 27 payments
  2. DA VINCI SP $2,800 2 payments
  3. INTERSTIM $644 6 payments
  4. Irrisept $36 1 payment
  5. Integra Recon-Skin And Wound $21 1 payment
  6. Integra Recon-Skin And Wound $21 1 payment
  7. INTEGRA DERMAL REGENERATION TEMPLATE $21 1 payment
  8. OMNIGRAFT $21 1 payment
  9. SURGIMEND $21 1 payment
  10. Harmonic $19 1 payment
  11. Other $53 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

119

Median for Colorectal Surgery (Proctology): 106

Drug cost

$460

Median for Colorectal Surgery (Proctology): $1,614

Branded share of claims

0%

Median for Colorectal Surgery (Proctology): 35.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 11 $145
Ondansetron Hcl Generic 25 $122
Neomycin Sulfate Generic 29 $118
Potassium Chloride Generic 25 $38
Metronidazole Generic 29 $38

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$24,663

Medicare's payments for the services billed

Medicare patients

68

Average age 73

Services billed

157

37 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 53%
Depression 26%
Chronic kidney disease 24%
Diabetes 22%
Ischemic heart disease 22%
Osteoporosis 21%
Cancer 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

39 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record